« Back to Record
Citation APA

Kim, C., Tang, G., Pogue-Geile, K. L., Costantino, J. P., Baehner, F. L., Baker, J., Cronin, M. T., Watson, D., Shak, S., Bohn, O. L., Fumagalli, D., Taniyama, Y., Lee, A., Reilly, M. L., Vogel, V. G., McCaskill-Stevens, W., Ford, L. G., Geyer, C. E., Wickerham, D. L., Wolmark, N., & Paik, S. (2011). Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer. Journal of clinical oncology, 29(31), 4160-4167. doi:10.1200/JCO.2010.32.9615


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/148658

Kim, C., Tang, G., Pogue-Geile, K. L., Costantino, J. P., Baehner, F. L., Baker, J., Cronin, M. T., Watson, D., Shak, S., Bohn, O. L., Fumagalli, D., Taniyama, Y., Lee, A., Reilly, M. L., Vogel, V. G., McCaskill-Stevens, W., Ford, L. G., Geyer, C. E., Wickerham, D. L., Wolmark, N., & Paik, S. (2011). Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer. Journal of clinical oncology, 29(31), 4160-4167. doi:10.1200/JCO.2010.32.9615